메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Lundbeck to showcase amlenetug Phase 3 MASCOT trial de…

[ 메디채널 김갑성 기자 ] Details of the Phase 3 MASCOT trial investigating amlenetug for the treatment of patients with Multiple System Atrophy (MSA) will be presented at the International Congress of Parkinson's Disease and Movement Disorders® 20251-3 MSA is a rare, rapidly progressing, neurodegenerative disease with no approved treatments available4,5 The innovative design of the pivotal MASCOT trial aims to accelerate drug development for patients living with MSA1 Amlenetug has previously received Orphan Drug Designation (ODD) from the US FDA and the EMA in Europe, in addition to SAKIGAK
- 김갑성 기자
- 2025-10-02 16:41
ExQor Technologies Announces Advancement Toward Clin…

BOSTON, Oct. 2, 2025 -- Addressing Critical Unmet Medical Need ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform targeting Alzheimer's disease. Current Alzheimer's therapeutics are limited to slowing cognitive decline, but the company's preclinical data demonstrates something fundamentally different – the ability to reverse brain damage and promote regeneration. An additional trial is planned for frontotemporal dementia, while exploring other conditions affecting cognitive functi
- 김갑성 기자
- 2025-10-02 14:13
World Gym Corporation Advances Global Growth with Mexico MF…

Master Franchise Agreement to Bring Minimum of 30 Locations to Mexico; Company Adds Five New Locations Across Australia TAIPEI, Oct. 2, 2025 -- World Gym Corporation (2762.TW) ("World Gym" or the "Company"), the owner of the iconic World Gym brand with over 270 locations worldwide, today announced significant progress in its global growth initiatives, highlighted by a Master Franchise Agreement (MFA) in Mexico and surging growth across Australia. The MFA will bring a minimum of 30 new World Gym facilities to Mexico while the Company has added five new locat
- 김갑성 기자
- 2025-10-02 08:30
Kolmar Korea Presents "K-Beauty Success Roadmap" in Ama…

Official manufacturing sponsor of Amazon Beauty in Seoul 2025, attracting over 3,000 online and offline participants Vice Chairman Sang-Hyun Yoon emphasizes the evolution toward blockbuster products as the key driver of K-Beauty's global success SEOUL, South Korea, Oct. 1, 2025 -- Kolmar Korea, a leading global ODM(Original Development Manufacturing) company, joined forces with Amazon to present a strategic roadmap for the worldwide expansion of K-Beauty. The company underscored that differentiated competitiveness built on technological expertise is the central element o
- 김갑성 기자
- 2025-10-01 22:12
Vatech Launches 'Boundless Campaign' to Eliminate Barrie…

First milestone: reduced device operation time update eases discomfort for elderly and disabled patients SEOUL, South Korea, Oct. 1, 2025 -- Vatech (KOSDAQ: 043150), a global leader in dental imaging solutions, today announced the launch of its 'Boundless Campaign' a long-term initiative aimed at creating a world where no one is excluded from dental care. The campaign integrates technology innovation and corporate social responsibility (CSR), addressing challenges faced by patients who struggle to access dental services—including elderly patients with mobil
- 김갑성 기자
- 2025-10-01 21:00
Gene Solutions and AMPATH Launch Advanced Genomics L…

HYDERABAD, India, Oct. 1, 2025 -- Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aims to bring high-value, next-generation sequencing (NGS) technologies closer to patients and healthcare providers across the country. By combining AMPATH's extensive diagnostic network with Gene Solutions' expertise in genomics, the partnership will enable more timely,
- 김갑성 기자
- 2025-10-01 20:01
CMEF 2025: Innovation Drives Global Synergy in Healthcare Eco…

GUANGZHOU, China, Oct. 1, 2025 -- The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition, organized by Reed Sinopharm Exhibitions, was held from September 26–29 at the Canton Fair Complex in Guangzhou. Covering nearly 160,000 square meters, the event gathered 3,000+ exhibitors from 20 countries and regions, presenting 10,000+ new products to 120,000 professional visitors from over 160 countries. CMEF reaffirmed its role as a globally influential hub for healthcare innovation and high-quality development. Over four decades, CMEF has evolved into a prem
- 김갑성 기자
- 2025-10-01 20:00
MD Logistics Makes Largest Indiana Business Location Fu…

[ 메디채널 김갑성 기자 ] - Total Area of 37,000m2, Enhanced Pharmaceutical Logistics Capacity - TOKYO, Oct. 1, 2025 -- MD Logistics LLC (hereinafter "MD Logistics"), a group company of NIPPON EXPRESS HOLDINGS, INC., completed renovation of the South Area of its largest logistics base in Plainfield, in the U.S. state of Indiana in July. As a result, the entire facility, with a total area of approximately 37,000m2, will begin operating as a cGMP*-compliant facility dedicated to pharmaceutical products. Logo: https://drive.google.com/file/d/1dqm0cxpYamnvMUra1AGXMuGlX932Z353/view
- 김갑성 기자
- 2025-10-01 15:00
Major Health Management Wins the 2025 Health Brand Awards…

TAIPEI, Oct. 1, 2025 -- Taiwan's leading health management brand, Major Health Management, has been honored with the Excellence Award in Health Technology – Health Examination Platform at the 2025 Health Brand Awards. This award is a highly regarded annual recognition in the health industry, representing professionalism, credibility, and social impact. The accolade not only highlights MJ's 38 years of dedication to preventive medicine, but also reflects its successful integration of big data and health technology in upgrading Taiwan's health examination services. 38 Year
- 김갑성 기자
- 2025-10-01 14:51
TAHO Pharma Announces Submission of New Drug Applicatio…

TAIPEI, Oct. 1, 2025 -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world's first Apixaban Oral Dissolving Film (ODF). This submission marks a significant regulatory milestone in TAHO Pharma's mission to bring innovative and accessible therapies to patients worldwide. TAH3311 is an innovative formulation designed to improve the delivery of apixaban, a widely used anticoagulant. Stroke affects more than 15 million people worldwide each year according t
- 김갑성 기자
- 2025-10-01 14:16

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-10-21_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 21일 16시 20분